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MinireviewNuclear RNA Turnover
An RNA can then be targeted for decay by deadenyla-Melissa J. Moore1
Howard Hughes Medical Institute tion, decapping, displacement of bound proteins, dis-
ruption of its tertiary structure, or endonucleolytic cleav-Department of Biochemistry
Brandeis University age at an internal site. Once an end is accessible, there
exist both 3 to 5 and 5 to 3 exonucleases that can415 South Street
Waltham, Massachusetts 02454 degrade it in either direction.
The nuclear RNA degradation machinery has been
best characterized in budding yeast, where the predomi-
nant nuclear decay pathway is 3 to 5 (Bousquet-Anto-In mammalian cells, significantly more RNA is turned
over in the nucleus than in the cytoplasm. However, nelli et al., 2000). Most of this activity is provided by
the exosome (van Hoof and Parker, 1999; Mitchell andonly recently have we begun to understand the mecha-
nisms and regulation of nuclear RNA decay. Tollervey, 2000), also known affectionately as the “Death
Star of RNA.” Discovered in the Tollervey lab, the exo-
some is a complex of ten to eleven proteins, most ofHigher eukaryotes are remarkably wasteful in their me-
which have 3 to 5 exonuclease activity in vitro or aretabolism of RNA. In mammals, only 50% of the nucleo-
presumed exonucleases based on sequence homology.tides incorporated by RNA polymerase I (Pol I) end up
Accessory factors include RNA helicases, a putativein mature ribosomes. The remainder is trimmed away
GTPase, and proteins that target the exosome to partic-in the nucleolus by the pre-rRNA processing machinery.
ular RNA sequences. Initially characterized as the spe-Pol II transcripts fair even worse, with less than 5%
cies responsible for 3 end maturation of 5.8S rRNA,of their nascent phosphodiester bonds making it into
nuclear exosomes are also required for 3 processingcytoplasmic mRNA. Typically, nine out of ten nucleo-
of snRNAs and snoRNAs and for the degradation of pre-tides in human Pol II transcripts are removed as introns
rRNA spacer regions. All of the exosomal subunits areand recycled within the nucleus. The remaining exonic
conserved in humans, where the complex is synony-sequences are subject to additional quality control steps
mous with the PM-Scl particle, a target of autoimmunewhile still associated with the nucleus to eliminate
antibodies (van Hoof and Parker, 1999; Mitchell andmRNAs with incomplete open reading frames or other
Tollervey, 2000, and references therein).deformities (Figure 1). Although no definitive numbers
Exosomes also function in the cytoplasm, where theyexist that quantify how much Pol II-transcribed RNA is
are required for 3 to 5 decay of deadenylated mRNAslost to such quality control, it has been estimated that
(van Hoof and Parker, 1999). Cytoplasmic exosomesonly 50% of transcripts reaching the 3 end of the dys-
differ from their nuclear counterparts in that they lacktrophin gene, the longest in the human genome, yield
one subunit, the nuclear protein Rrp6p. While the tenmature nuclear mRNAs (Jackson et al., 2000, and refer-
core subunits are all essential for growth, deletion ofences therein). Pol III transcripts (e.g., 5S RNA and
Rrp6p only causes temperature-sensitive lethality. CellstRNAs) are also subject to trimming and splicing before
lacking Rrp6p activity accumulate stable nuclear RNAsexiting the nucleus. Thus, the bulk of RNA turnover in
with incompletely processed 3 ends. Rrp6p has alsomammalian cells occurs in the nucleus, not the cyto-
been implicated in the turnover of nuclear pre-mRNAsplasm. However, in contrast to cytoplasmic mRNA de-
and mRNAs, and the retention near the transcriptioncay, which has been studied extensively for the past
site of mRNAs containing aberrant 3 ends (Burkard anddecade as a key regulatory step in gene expression,
Butler, 2000; Hilleren et al., 2001; and see below).nuclear RNA turnover is still largely unexplored territory.
There is also evidence for a 5 to 3 exonucleolyticThis minireview will focus on recent progress in this
decay pathway in the nucleus. S. cerevisiae containsarea.
two known 5 to 3 exonucleases, Rat1p and Xrn1p,The Nuclear RNA Degradation Machinery
both of which are conserved throughout eukaryotes.Like intracellular protein degradation, intracellular RNA
Rat1p is predominantly nuclear and is essential. It isdegradation must be closely regulated so as to prevent
known to be involved in pre-rRNA processing andwholesale elimination of all transcripts. The intracellular
snoRNA maturation, and may also function in mRNARNA degradation machinery is largely exonucleolytic,
maturation, as temperature-sensitive rat1-1 cells rapidlyallowing RNAs to escape decay simply by protecting
their ends. The 5 ends of Pol II transcripts are protected accumulate nuclear polyA RNA after shift to restrictive
by a 7mGpppG cap structure, which is added almost temperature. The Xrn1p enzyme provides the major de-
immediately after transcript initiation, and then further cay pathway for deadenylated and nonsense-containing
protected via nuclear and cytoplasmic cap binding pro- mRNAs in the cytoplasm, although it is not an essential
teins. At the other end, the 3 polyA tail is sequentially protein. When their subcellular localizations are altered,
bound by nuclear and cytoplasmic polyA binding pro- both Rat1p and Xrn1p are functionally interchangeable,
teins. Other RNAs, such as rRNAs, snRNAs, snoRNAs, and even under normal conditions, Xrn1p appears to
and tRNAs, carry alternate cap structures, tightly-bound overlap Rat1p’s functions in the nucleus (for references,
proteins, and/or strong structural elements at their ends. see Geerlings et al., 2000; Xue et al., 2000). Although
Rat1p and the exosome constitute the major nuclear
decay machinery known to date, because our knowl-1Correspondence: mmoore@brandeis.edu
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Figure 1. Nuclear Routes of Processing and
Turnover for RNA Pol II Transcripts
Nuclear processing of Pol II transcripts includes
capping, excision of introns, and addition of
a polyA tail. The nuclear RNA degradation
machinery consists largely of exonucleases,
the best characterized of which are the exo-
some and Rat1p. In addition to degrading ex-
cised introns, nuclear exonucleases appear
to assist in the elimination of inefficiently pro-
cessed pre-mRNAs and malformed mRNAs.
edge is limited, there could well exist other important unit Rrp6, alleviated the transcription site accumulation
of hypo- and hyperadenylated mRNAs (Hilleren et al.,degradative enzymes that await characterization.
Nuclear Discard Pathways for Inefficiently 2001). Thus, in addition to its exonucleolytic activities,
another function of the exosome may be to retain at theand Improperly Processed Transcripts
In S. cerevisiae, mutations in pre-mRNA splicing factors site of transcription mRNAs that lack appropriate length
polyA tails, or are otherwise malformed. Consistent withcan dramatically reduce spliced mRNA levels without
concomitantly increasing the levels of unspliced pre- such a role, Rrp6 interacts genetically and physically
with both the polyA polymerase and a nucleocytoplas-mRNAs. This implies the existence of an efficient pre-
mRNA discard pathway. Recently, the Tollervey lab mic shuttling protein, Npl3p, involved in mRNA export
(Burkard and Butler, 2000). Further experiments will bedemonstrated that such a pathway does operate in
S. cerevisiae (Bousquet-Antonelli et al., 2000). They required to determine whether the degradative and
mRNA retention functions of the exosome are equallyfound that when exosome mutations (exo) were com-
bined with a strong splicing mutation (prp2-1), pre- dependent on intact exonuclease active sites or are
functionally separable. Also, it will be of great interest tomRNA levels rose 20- to 50-fold over the levels observed
with the prp2-1 mutation alone. Surprisingly, spliced investigate such quality-control pathways in mammalian
cells, where the proliferation of alternative splicing andmRNA levels also increased significantly in the exo
prp2-1 cells over exo prp2-1 cells. These and other alternative polyadenylation are likely accompanied by
significantly increased frequencies of processing errors.data suggest that the exosome normally degrades pre-
mRNAs that are not efficiently processed, but when Nonsense-Mediated mRNA Decay
A more extensively studied quality-control system thanthese pre-mRNAs are not degraded, they can be slowly
spliced in the prp2-1 background. Consistent with the those described above is the nonsense-mediated mRNA
decay (NMD) pathway (Maquat and Carmichael, 2001;notion that there is dynamic competition between splic-
ing of nascent transcripts and their degradation by the Wilusz et al., 2001). This is a means for eliminating
mRNAs with incomplete open reading frames, therebyexosome, disruption of exosome activity alone in an
otherwise wild-type background increased the steady- preventing synthesis of potentially deleterious, trun-
cated proteins. Such mRNAs can arise by genetic muta-state levels of both pre-mRNAs and spliced mRNAs.
However, the same mutations had little effect on the tion (e.g., frameshift and nonsense mutations), through
transcriptional and processing errors, or via the naturalsteady-state level of an unspliced mRNA, suggesting
that intronless mRNAs may not be efficient substrates gene rearrangement process required for lymphocyte
development. Studies in budding yeast are consistentfor nuclear 3 to 5 decay in budding yeast.
In another recent study, the exosome was linked to with NMD being a purely cytoplasmic process. Support-
ing this idea are observations that NMD involves thea quality-control system for monitoring proper mRNA
3-end formation. In S. cerevisiae, both hypo- and hyper- normal translation apparatus, which upon recognition
of a premature termination codon, triggers mRNA de-adenylated mRNAs are retained at or near the site of
transcription. Similarly, inefficiently processed transcripts capping without deadenylation and then 5 to 3 degra-
dation via the cytoplasmic Xrn1 exonuclease pathway.in mammalian cells accumulate around the transcription
site (Hilleren et al., 2001; and references therein). This On the other hand, experiments in mammalian cells
have clearly implicated the nucleus in NMD. Early experi-suggests the existence of surveillance systems that in-
hibit transcription site release of RNAs that have not ments relying on biochemical separation of the nuclear
and cytoplasmic compartments revealed that manybeen properly processed. Remarkably, a recent study
in S. cerevisiae revealed that mutation of three different mammalian mRNAs containing truncated open reading
frames are found at lower levels than the correspondingexosome subunits, including the nuclear-specific sub-
Minireview
433
wild-type mRNAs in both nuclear and cytoplasmic frac- Intron Degradation
Even though introns represent up to 90% of the nucleo-tions. A popular hypothesis to explain this phenomenon
tides incorporated by RNA Pol II in the nuclei of higheris that mammalian mRNAs are subject to reading frame
eukaryotes, until recently very little attention has beenrecognition by cytoplasmic ribosomes coincident with
paid to the metabolism of these sequences once theynuclear export. In this way, a prematurely truncated
have been spliced out. Although a few introns have regu-open reading frame could be detected and the offending
latory roles or encode small nucleolar RNAs (snoRNAs),mRNA degraded before it is ever released from the nu-
the majority are thought to have no specific function.clear pore complex. However, some recent studies have
After splicing, they must be disassembled from therekindled an old idea that there may actually be reading
spliceosome and degraded. Due to their lariat structure,frame recognition and even translation within the nu-
a requisite step in intron degradation is cleavage ofcleus itself. First, subcellular localization studies have
the 2-5 phosphodiester bond at the branch site. Thisshown that not only is Upf3p, a protein required for NMD,
reaction is carried out by an evolutionarily conservedpredominantly nuclear in mammalian cells, significant
debranching enzyme, deletion of which confers a severeamounts of the cytoplasmic translation factors eIF4E
growth defect in Schizosaccharomyces pombe (Nam etand eIF4G are also found in the nucleus (for references,
al., 1997). While lack of this enzyme is of little phenotypicsee Iborra et al., 2001; Ishigaki et al., 2001; Muhlemann
consequence in S. cerevisiae, which has relatively fewet al., 2001). The nuclear fraction of the latter factors
introns compared to S. pombe and higher eukaryotes,(10% of total) is similar to the fraction of protein syn-
debranching-deficient S. cerevisiae cells do accumulate
thesis recently attributed to the nuclei of permeablized
circular introns missing the lariat tail (Chapman and
mammalian cells (Iborra et al., 2001). The nuclear associ- Boeke, 1991). This suggests that, like other nuclear
ation of newly made proteins observed by Iborra et al. RNAs, the main degradation pathway for debranched
is dependent on ongoing transcription, and RNA/protein introns is an exonucleolytic one. However, which exo-
colabeling techniques revealed that newly made nuclear nucleases are responsible is not yet known.
proteins colocalize with newly made RNAs. If translation Recently, the Wilkinson lab showed that the half-lives
does occur in the nucleus, to what extent does it involve of four mammalian introns after splicing were surpris-
predominantly nuclear factors? A partial answer to this ingly long, ranging from 6 to 29 min. Such half-lives are
came from the Maquat lab, which showed that the first, comparable to naturally unstable mRNAs such as c-myc
or “pioneering,” round of translation and this leads to and c-fos (Clement et al., 2001; and references therein).
NMD occurs while mammalian mRNAs are still bound Given that the longest intron in that study was 2.4 kb,
by the nuclear cap binding complex and nuclear polyA and the half-lives of the introns they examined correlated
binding protein (Ishigaki et al., 2001). Finally, the Moore loosely with length, it may now be of interest to deter-
and Wilkinson labs reported that disruption of mRNA mine whether longer introns have even longer half-lives
reading frame can lead to accumulation of unspliced and whether introns that are significantly more stable
pre-mRNAs at or near the transcription site of the mutant than the mean have any regulatory consequences for
allele (Muhlemann et al., 2001). This result opens the gene expression.
tantalizing possibility that, as in bacteria, reading frame Nuclear Stabilization of Unstable mRNAs
Many mRNAs are naturally short-lived. This is an impor-recognition in mammalian cells might even occur cotran-
tant control mechanism for temporally limiting the syn-scriptionally. As of this writing, it remains to be deter-
thesis of the encoded proteins (e.g., cytokines andmined whether the pre-mRNAs that accumulate upon
growth factors). Such mRNAs often contain instabilitydisruption of reading frame represent molecules in line
elements in their 3UTRs. One well-studied instabilityfor mRNA synthesis and then NMD, or molecules that
element is the ARE, or AU-rich element (Brennan andhave somehow been targeted for destruction prior to
Steitz, 2001; Guhaniyogi and Brewer, 2001). Recently,splicing. Also, it is currently unknown what relationship,
it was shown that this element destabilizes an mRNA byif any, exists between these transcription site accumula-
attracting exosomes to it (Chen et al., 2001; Mukherjee ettions and those observed in yeast for mRNAs with aber-
al., 2002). Exosomes are recruited through direct inter-rant 3 ends (Hilleren et al., 2001; see above).
action with the ARE (Mukherjee et al., 2002), as wellIf some or most NMD does occur inside the mamma-
as through adaptor proteins that bridge the ARE andlian nucleus, it will be of great interest to determine
exosome (Chen et al., 2001). Given that exosomes puri-
which exonuclease pathway is involved. Does NMD of
fied from both nuclear and cytoplasmic compartments
nuclear mRNAs involve deadenylation-independent de- stimulate degradation of ARE-containing mRNAs (Chen
capping and then 5 to 3 decay, as does cytoplasmic et al., 2001), one wonders how ARE-containing mRNAs
NMD in S. cerevisiae? If so, what is the decapping en- are ever able to run the gauntlet of exosomes in the
zyme and which 5 to 3 exonuclease ortholog (Rat1p, nucleus and escape intact to the cytoplasm. The answer
Xrn1p, or a novel enzyme) is involved? Or, given that lies in the existence of repressor proteins that bind ARE
the exosome is the more active exonuclease in the nu- sequences in the nucleus and prevent efficient exosome
cleus of budding yeast (Bousquet-Antonelli et al., 2000), acquisition in that compartment. One such protein is
perhaps mammalian NMD is a predominantly 3 to 5 HuR, a member of the ELAV family of RNA binding pro-
degradation pathway. Recent work showing that the teins. HuR is a predominantly nuclear shuttling protein,
exosome is attracted to naturally short-lived mRNAs by overexpression of which stabilizes ARE-containing mRNAs.
proteins bound to instability elements (see below), might In addition to fending off nuclear exosomes, HuR also
suggest a parallel mechanism for exosome attraction to helps shepherd ARE-containing mRNAs out of the nu-
cleus via an alternate mRNA export pathway. Once inmRNAs destined for NMD.
Cell
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the cytoplasm, HuR remains bound long enough for the
ARE-containing mRNAs to be taken up into polysomes
(Brennan and Steitz, 2001). Presumably, the eventual
dissociation of HuR and its return to the nucleus then
allows association of cytoplasmic exosomes with ARE-
containing mRNAs, resulting in rapid decay. It is cur-
rently unknown whether HuR dissociation is a passive
process dependent solely on its dissociation constant
and lower concentration of HuR in the cytoplasm, or
whether the translation machinery assists in HuR re-
moval to actively limit the number of protein molecules
translated from ARE-containing RNAs.
In summary, although our understanding of the ma-
chinery and regulation of RNA turnover in the nucleus is
rapidly increasing, it is clear that many more revelations
await. Among those revelations will undoubtedly be mul-
tiple surprises. Study of NMD in higher eukaryotes is
already pushing our perceptions as to the extent to
which RNA processing and translation are physically
compartmentalized in eukaryotic cells. The elucidation
of other nuclear decay pathways may well reveal a level
of interplay between the RNA processing and decay
machineries that we can only now just imagine.
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